A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD

May-12

AUTHORS : Dr Michele Jara, Acorda Therapeutics, Inc., 420 Saw Mill, River Road, Ardsley, NY 10502, USA – Email: mjara@acorda.com OR Dr Stephan Lanes (Details for this study: Department of Epidemiology and Database Analytics, United Biosource Corporation, Lexington, Massachusetts, USA), now working at HealthCore, Wilmington Office, 123 Justison Street, Suite 200, Wilmington, DE 19801, United States – Email: slanes@healthcore.com – Profile: https://www.healthcore.com/experts/stephan-lanes-phd-mph/

JOURNAL : BMJ Open

REFERENCE: 2(3):e000841

DOI : 10.1136/bmjopen-2012-000841

A new user cohort study comparing the safety of long-acting inhaled bronchodilators in COPD

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study